Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicare Part B, Breakthrough Drugs Get Reimbursement Boost In Senate COVID-19 Bill

Mar 22 2020

• By Cathy Kelly

United States Capitol Building in Washington DC USA — Bill Aims To Enhance Medicare Payments To Bolster Care, Innovation

Related Content

Supply Chain Resilience Measures Included In Senate Coronavirus Bill

Mar 22 2020

Antibiotics May Finally Get Better Medicare Payments Under US Senate COVID-19 Aid Package

Mar 22 2020

Coronavirus Product Communications Would Get Safe Harbor Under Senate Bill

Mar 22 2020

Buying The Coronavirus Vaccine: What Would A ‘Fair And Reasonable’ Price Be?

Mar 06 2020

Code Break: Medicare Accelerates ‘J-Code’ Assignment To Boost Uptake Of New Drugs

Sep 04 2019

Medicare Final CAR-T Policy Eases Coverage Requirements

Aug 08 2019

Medicare To Use Evidence Development For Off-Label Drug Use? CMS Guidance Unclear

Nov 25 2014

Oncologists Move Against Medicare Part B Drug Payment, Pricing ‘Attacks’

Jun 01 2018

Additional Topics

United States Coronavirus COVID-19 Legislation Reimbursement Government Payers BioPharmaceutical

More from Medicare

More from Government Payers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window